Journal
LANCET
Volume 383, Issue 9911, Pages 69-82Publisher
ELSEVIER SCIENCE INC
DOI: 10.1016/S0140-6736(13)60591-7
Keywords
-
Categories
Funding
- National Institutes of Health
- Juvenile Diabetes Research Foundation
- American Diabetes Association
- Brehm Coalition for Type 1 Diabetes research
- Children's Diabetes Foundation
- Helmsley Trust
- Jeffrey Keene Family Professorship
Ask authors/readers for more resources
Over the past decade, knowledge of the pathogenesis and natural history of type 1 diabetes has grown substantially, particularly with regard to disease prediction and heterogeneity, pancreatic pathology, and epidemiology. Technological improvements in insulin pumps and continuous glucose monitors help patients with type 1 diabetes manage the challenge of lifelong insulin administration. Agents that show promise for averting debilitating disease-associated complications have also been identifi ed. However, despite broad organisational, intellectual, and fi scal investments, no means for preventing or curing type 1 diabetes exists, and, globally, the quality of diabetes management remains uneven. This Seminar discusses current progress in epidemiology, pathology, diagnosis, and treatment of type 1 diabetes, and prospects for an improved future for individuals with this disease.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available